Trademark information
IP India · live recordApplication ID
5530889
Status
Abandoned
Sub status
Not Applicable
Date of application
15 July 2022
Classes
5
Type
Word
Proprietor
Glenmark Pharmaceuticals Public
B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026
Attorney
Vishesh And Associates[10756]301/302, A Wing, 3 Rd Floor, Shaheen Chambers, Dawood Baug, Opp. Pearl Heritage,Andheri (West), Mumbai 400 058.
State
Maharashtra
Filing mode
e-Filing
IP office
Mumbai
Used since
—
Valid / upto
—
Goods & services
Class 5Class 5PHARMACEUTICAL, MEDICINAL AND AYURVEDIC PREPARATIONS AND SUBSTANCES, DIETETIC FOOD AND SUBSTANCES ADAPTED FOR MEDICAL USE, DIETARY SUPPLEMENTS FOR HUMANS, NUTRITIONAL SUPPLEMENTS, NUTRACEUTICAL PREPARATIONS FOR THERAPEUTIC OR MEDICAL PURPOSES, NUTRACEUTICALS FOR USE AS DIETARY SUPPLEMENTS
Uploaded documents
Sign in to open
1
TM-A(TRADE MARKS APPLICATION)
15 Jul 2022
2
Reply to Exam Report (MIS-R)
19 Dec 2022
3
Authorization Letter
13 Mar 2024
4
Documents in support of Show cause Hearing (SCH)
15 Mar 2024
5
Authorization Letter
23 Aug 2024
6
Journal Copy
09 Sep 2024
7
TM-O(NOTICE OF OPPOSITION)
29 Oct 2024
8
TM-O(NOTICE OF OPPOSITION)
08 Jan 2025
9
TM-O(NOTICE OF OPPOSITION)
08 Jan 2025
Correspondence and notices
1
EXAMINATION REPORT
14440470
06 Dec 2022
2
Hearing Notice (Show Cause)
17525798
24 Feb 2024
3
Hearing Notice (Show Cause)
18320304
14 Jun 2024
4
Tribunal Accepted Notice for : 5530889
18769367 · 6887171
28 Aug 2024
5
Opposition Notice
19344459 · 7034277
18 Dec 2024
6
Opposition Notice
19502330 · 7076402
15 Jan 2025
7
Opposition Notice
19502397 · 7076427
15 Jan 2025
8
Order Form of 21(2)
20621777 · 7354613
25 Jul 2025
9
Order Form of 21(2)
20621784 · 7354614
25 Jul 2025
10
Order Form of 21(2)
20621788 · 7354615
25 Jul 2025
Frequently asked questions
Norp was applied for on 15 July 2022.
The application was filed by Glenmark Pharmaceuticals.
Class 5.
As per IP India, the status is Abandoned.
The listed application ID of Norp is 5530889.
Trademark attorney Vishesh And Associates.